Policy Manual Definitions
Browse definitions of the technical terms in the Research Integrity Policy Manual.
Oversight of Human Research Protection
- 1. The University's Human Research Protection Program
- 2. Institutional Authority for Human Research Protection
- 3. Designation of IRB for Non-Exempt Human Research
- 4. The Role of Non-University of Nevada, Reno (External) IRBs, Single IRB and Independent Investigator Agreements
- 5. Independence of the University's IRBs
- 6. Flexibility Policy
- 21. Training Requirements for Human Research
- 25. Responsibilities: Responsible Official
- 26. Responsibilities - Research Integrity Director and Staff
- 27. IRB Committee Membership
- 30. Responsibilities of IRB Members, Chair, and Co-Chair
- 35. Requirements and Responsibilities of Principal Investigators for Human Research Projects
- 38. Responsibilities - Researchers
- 48. Outreach to Research Participants and the Community
Overview: Ethical Standards and Federal Regulations for Human Research Subjects
- 50. Ethical Foundation - The Belmont Report
- 51. DHHS Regulations for the Protection of Human Research Participants
- 52. DHHS Regulations - The Common Rule
- 53. DHHS Regulations - Criteria for IRB Approval
Agency-Specific Requirements for Human Subject Research
- 60. Department of Defense (DoD) Regulations for Human Research
- 75. Department of Education (DoEd) Regulations for Human Research
- 76. Additional DoEd Regulations - Family Educational Rights and Privacy Act (FERPA)
- 77. DoEd: Exceptions to FERPA Requirements
- 78. Additional DoEd Regulations - Protection of Pupil Rights Amendment (PPRA)
- 80. Department of Energy (DoE) Regulations for Human Research
- 85. Department of Justice (DoJ) Regulations for Human Research Protection
- 90. Environmental Protection Agency (EPA) Regulations for Human Research
- 100. Overview of FDA Regulations, Information Sheets and Guidance
- 101. FDA Regulations for the Protection of Human Research Participants
- 105. FDA Regulations for IRB Review and Approval
- 110. Investigational Drug Research
- 115. FDA Regulations for Treatment or Emergency Uses of Investigational Drugs
- 120. Investigational Device Research and Exempted Device Investigations
- 125. Humanitarian Use Devices
- 130. Emergency, Compassionate, Treatment, and Continued Uses of Investigational Devices
- 135. Clinical Trial Requirements
- 137. HIPAA and Human Research Conducted under the University's Human Research Protection Program
- 140. VA Regulations and Requirements for the Protection of Human Participants: Overview
- 145. Additional VA Requirements - Recruitment and Consent
- 150. Additional Requirements for VA Research Involving Vulnerable Populations
- 155. Additional Requirements - IRB Review and Documentation for VA Research
- 165. Problems in VA Research - Reporting, Review, and Notification
- 170. Nevada State Laws for Human Research
- 175. Process for Resolving Conflicts Between Federal, State, and Local Laws
Research Populations
- 200. Selection of Research Participants
- 201. Exempt Research and Vulnerable Populations
- 210. Research Involving Pregnant Women, Fetuses, and Neonates
- 211. Research with Pregnant Women or Women with the Potential to Become Pregnant
- 215. Research Involving Prisoners
- 216. Unexpected Incarceration of a Research Participant
- 230. Research Involving Children
- 240. Research Involving Adults with Impaired Decision-Making Capacity
- 246. Research Involving Economically or Educationally Disadvantaged Persons
- 250. Research Involving Persons Who Do Not Speak English
- 280. For Investigators Conducting International Research
- 285. Secondary Use of Data
Recruitment and Consent
- 300. Recruitment Settings and Procedures
- 302. Recruitment Materials and Combined Recruitment/Consent Materials
- 305. Inherently Influential Recruitment Situations
- 308. Recruitment Incentives/Payment for Participation
- 310. Assessing for Eligibility
- 315. Requirements for Recruitment by External Researchers
- 325. Informed Consent Requirements
- 326. Short Form Written Consent Documentation
- 330. Informed Consent - Greater than Minimal Risk Research
- 335. Waiver/Alteration of Informed Consent and Waiver of Documentation of Consent
- 340. Informed Consent for Exempt and Minimal Risk Research
- 342. Informed Consent and Incomplete Disclosure or Deception
- 343. Informing Participants of Research Costs
- 345. Photo and Video Release Forms
- 346. Consent and Early Withdrawal or Cessation of Participation
Risks, Benefits, and Safety Monitoring
- 351. Research Risks
- 360. Benefits
- 370. Assessing Reasonableness of Risks in Relation to Benefits
- 375. Monitoring Data for Participant Safety
Privacy and Confidentiality
- 400. Participant Privacy versus Data Confidentiality
- 405. Protecting Participant Privacy
- 410. Maintaining Data Confidentiality
- 420. Disclosing Findings to Participants
- 425. Certificates of Confidentiality
Submission Requirements
- 500. Submission Types in IRBNet
- 501. Requirements for External Investigator to Use a University IRB
- 506. New Projects - Submitting for Human Research Determination
- 507. New Projects that May or May Not Be Human Research
- 510. New Projects - Submission Requirements for Full Committee Review
- 511. New Projects - Submission Requirements for Expedited Review
- 512. New Projects - Submission Requirements for Exempt Review
- 513. New Projects - Submission Requirements for Administrative Review
- 515. Continuing Review: Submission Requirements for Full Committee Review
- 516. Continuing Review or Progress Report: Submission Requirements for Expedited Studies
- 518. Updated Documentation for Use of External IRB
- 520. Project Amendments: Overview of Requirements
- 521. Submitting Amendments for Full Committee or Expedited Review
- 522. Changes to Personnel or Study Sites for Non-Exempt Research
- 540. Closing a Research Project Involving Human Participants
Review Types and Processes
- 550. Research Integrity Oversight and IRB Review
- 551. IRB Review Types
- 552. Research Integrity Assessment for Completeness and Review Type
- 556. Reviewer Assignment and Notification
- 557. Using Consultants for IRB Reviews
- 559. Review Materials and Worksheets
- 560. New Projects: Full Committee Review
- 561. New Projects: Expedited Review
- 562. Continuing Reviews, Full Committee
- 563. Continuing Reviews, Expedited
- 564. Amendment Reviews, Full Committee
- 565. Amendment Reviews, Expedited
- 566. Exempt Review and Approval
- 574. IRB Review of Community Based Participatory Research
- 575. IRB Review of International Research
- 576. IRB Review of Research with Potentially Hazardous Biological Agents
- 580. Documentation of Reviewer Recommendations
- 585. IRB Actions
- 590. Notifying Investigators and Others of Review Results
- 591. IRB Requested Revisions: Investigator Response and IRB Review
- 595. Determining Dates for Full Committee and Expedited Reviews
IRB Records
- 600. Evaluation of IRB Membership and Selection of Reviewers
- 610. Project Status
- 615. Using Consultants for IRB Reviews
- 626. IRB Minutes
- 630. IRB Meetings
- 650. IRB Records
Problems
- 700. Reporting Complaints and Problems in Research
- 705. Assessment of Complaints and Problems in Research
- 720. Noncompliance
- 730. Unanticipated Problems Involving Risks to Participants or Others
- 735. Protocol Deviations
- 740. Suspensions or Terminations of IRB Approval
- 750. IRB Notification Requirements for Reportable Events
Quality Improvement Program
- 800. Quality Improvement Program
- 801. Random Scheduled Review
- 802. Directed On-Site Review
- 803. Informed Consent Review
- 804. Internal Assessment Review
- 815. Educational Outreach